Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.428.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.459NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.415.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.243.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.566NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.480NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.579NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.11 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.435NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.445NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.124NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.569NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.524NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.596.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.473NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.76.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used